Suncare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-07-2024
- Paid Up Capital ₹ 0.95 M
as on 24-07-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.70 Cr
as on 24-07-2024
- Satisfied Charges ₹ 2.24 Cr
as on 24-07-2024
About Suncare Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹4.70 Cr. The company has closed loans amounting to ₹2.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Sikaria and Sandeep Sikaria serve as directors at the Company.
- CIN/LLPIN
U31104UT2002PTC017112
- Company No.
094759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2002
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Suncare Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Sikaria  | Director | 18-Jun-2002 | Current |
| Sandeep Sikaria | Director | 18-Jun-2006 | Current |
Financial Performance and Corporate Structure Insights of Suncare Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Suncare Pharmaceuticals?
Unlock access to Suncare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Suncare Formulations Private LimitedActive 20 years 1 monthSanjay Sikaria and Sandeep Sikaria are mutual person
Suncare Laboratories LlpActive 3 years 4 monthsSanjay Sikaria and Sandeep Sikaria are mutual person
- Fulwari Greens Properties Private LimitedActive 10 years 2 months
Sanjay Sikaria and Sandeep Sikaria are mutual person
- Uni-Scientific Research And Analytical FoundationActive 3 years 1 month
Sanjay Sikaria is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 Sep 2020 | ₹4.00 Cr | Open |
Axis Bank Limited Creation Date: 19 Aug 2020 | ₹7.00 M | Open |
Bank Of Baroda Creation Date: 09 Oct 2009 | ₹2.24 Cr | Satisfied |
How Many Employees Work at Suncare Pharmaceuticals?
Unlock and access historical data on people associated with Suncare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suncare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suncare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
